Cargando…
OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767558/ http://dx.doi.org/10.1186/1742-4690-6-S3-O36 |
| _version_ | 1782173322072555520 |
|---|---|
| author | Baden, LR Dolin, R O'Brien, KL Abbink, P La Porte, A Seaman, MS Choi, E Tucker, R Weitjens, M Pau, MG Goudsmit, J Barouch, DH |
| author_facet | Baden, LR Dolin, R O'Brien, KL Abbink, P La Porte, A Seaman, MS Choi, E Tucker, R Weitjens, M Pau, MG Goudsmit, J Barouch, DH |
| author_sort | Baden, LR |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2767558 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2009 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-27675582009-10-28 OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector Baden, LR Dolin, R O'Brien, KL Abbink, P La Porte, A Seaman, MS Choi, E Tucker, R Weitjens, M Pau, MG Goudsmit, J Barouch, DH Retrovirology Oral Presentation BioMed Central 2009-10-22 /pmc/articles/PMC2767558/ http://dx.doi.org/10.1186/1742-4690-6-S3-O36 Text en Copyright © 2009 BioMed Central Ltd. |
| spellingShingle | Oral Presentation Baden, LR Dolin, R O'Brien, KL Abbink, P La Porte, A Seaman, MS Choi, E Tucker, R Weitjens, M Pau, MG Goudsmit, J Barouch, DH OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title | OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title_full | OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title_fullStr | OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title_full_unstemmed | OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title_short | OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector |
| title_sort | oa05-06 lb. first-in-human phase 1 safety and immunigenicity of an adenovirus serotype 26 hiv-1 vaccine vector |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767558/ http://dx.doi.org/10.1186/1742-4690-6-S3-O36 |
| work_keys_str_mv | AT badenlr oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT dolinr oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT obrienkl oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT abbinkp oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT laportea oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT seamanms oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT choie oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT tuckerr oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT weitjensm oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT paumg oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT goudsmitj oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector AT barouchdh oa0506lbfirstinhumanphase1safetyandimmunigenicityofanadenovirusserotype26hiv1vaccinevector |